We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · January 16, 2022

Differences Between Outcomes of COVID-19 Delta vs Beta Variant Infection in Qatar

JAMA Internal Medicine

 

Additional Info

Disclosure statements are available on the authors' profiles:

JAMA Internal Medicine
Severity of Illness in Persons Infected With the SARS-CoV-2 Delta Variant vs Beta Variant in Qatar
JAMA Intern Med 2021 Dec 22;[EPub Ahead of Print], AA Butt, SR Dargham, H Chemaitelly, A Al Khal, P Tang, MR Hasan, PV Coyle, AG Thomas, AM Borham, EG Concepcion, AH Kaleeckal, AN Latif, R Bertollini, AB Abou-Samra, LJ Abu-Raddad

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading